Calcium condensed LABL-TAT complexes effectively target gene delivery to ICAM-1 expressing cells

Molecular Pharmaceutics

Volumn 8, Issue 3, 2011, Pages 788-798

  Khondee, Supang ^a   Baoum, Abdulgader ^a   Siahaan, Teruna J ^a   Berkland, Cory ^a,b  

^a UNIVERSITY OF KANSAS   (United States)

^b University of Kansas   (United States)

Author keywords

calcium; ICAM 1; LABL; targeted gene delivery; TAT

Indexed keywords

CALCIUM; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1 LABL; MACROGOL; PEPTIDE; SPACER DNA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONJUGATION; CONTROLLED STUDY; DNA PROTEIN COMPLEX; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONVIRAL GENE DELIVERY SYSTEM; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PURIFICATION;

CALCIUM; CELL LINE, TUMOR; CELL SURVIVAL; DNA; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MICROSCOPY, CONFOCAL; PEPTIDES; POLYETHYLENE GLYCOLS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 79958265156     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp100393j     Document Type: Article

References (64)

1. Russ, V.; Wagner, E. Cell and tissue targeting of nucleic acids for cancer gene therapy Pharm. Res. 2007, 24 (6) 1047-1057 (Pubitemid 46798888)
2. Li, S. D.; Huang, L. Gene therapy progress and prospects: non-viral gene therapy by systemic delivery Gene Ther. 2006, 13 (18) 1313-1319 (Pubitemid 44323687)
3. Kirschberg, T. A.; VanDeusen, C. L.; Rothbard, J. B.; Yang, M.; Wender, P. A. Arginine-based molecular transporters: the synthesis and chemical evaluation of releasable taxol-transporter conjugates Org. Lett. 2003, 5 (19) 3459-3462 (Pubitemid 37487437)
4. Rothbard, J. B.; Garlington, S.; Lin, Q.; Kirschberg, T.; Kreider, E.; McGrane, P. L.; Wender, P. A.; Khavari, P. A. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation Nat. Med. 2000, 6 (11) 1253-1257
5. Bhorade, R.; Weissleder, R.; Nakakoshi, T.; Moore, A.; Tung, C. H. Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide Bioconjugate Chem. 2000, 11 (3) 301-305 (Pubitemid 30324895)
6. Kersemans, V.; Kersemans, K.; Cornelissen, B. Cell penetrating peptides for in vivo molecular imaging applications Curr. Pharm. Des. 2008, 14 (24) 2415-2427
7. Corradin, S.; Ransijn, A.; Corradin, G.; Bouvier, J.; Delgado, M. B.; Fernandez-Carneado, J.; Mottram, J. C.; Vergères, G.; Mauël, J. Novel peptide inhibitors of Leishmania gp63 based on the cleavage site of MARCKS (myristoylated alanine-rich C kinase substrate)-related protein Biochem. J. 2002, 367 (Part 3) 761
8. Datta, K.; Sundberg, C.; Karumanchi, S. A.; Mukhopadhyay, D. The 104-123 Amino Acid Sequence of the {beta}-domain of von Hippel-Lindau Gene Product Is Sufficient to Inhibit Renal Tumor Growth and Invasion Cancer Res. 2001, 61 (5) 1768
9. Fawell, S.; Seery, J.; Daikh, Y.; Moore, C.; Chen, L. L.; Pepinsky, B.; Barsoum, J. Tat-mediated delivery of heterologous proteins into cells Proc. Natl. Acad. Sci. U.S.A. 1994, 91 (2) 664
10. Wadia, J.; Dowdy, S. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer Adv. Drug Delivery Rev. 2005, 57 (4) 579-596 (Pubitemid 40255562)
11. Eguchi, A.; Akuta, T.; Okuyama, H.; Senda, T.; Yokoi, H.; Inokuchi, H.; Fujita, S.; Hayakawa, T.; Takeda, K.; Hasegawa, M. Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells J. Biol. Chem. 2001, 276 (28) 26204
12. Snyder, E. L.; Dowdy, S. F. Protein/peptide transduction domains: potential to deliver large DNA molecules into cells Curr. Opin. Mol. Ther. 2001, 3 (2) 147
13. Jesus, M.; Berry, C. C. Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus Bioconjugate Chem. 2005, 16 (5) 1176-1180 (Pubitemid 41368118)
14. Sethuraman, V. A.; Bae, Y. H. TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors J. Controlled Release 2007, 118 (2) 216-224 (Pubitemid 46350711)
15. Baoum, A.; Xie, S.; Fakhari, A.; Berkland, C. Soft" Calcium Crosslinks Enable Highly Efficient Gene Transfection Using TAT Peptide Pharm. Res. 2009, 26 (12) 2619-2629
16. Pedraza, C. E.; Bassett, D. C.; McKee, M. D.; Nelea, V.; Gbureck, U.; Barralet, J. E. The importance of particle size and DNA condensation salt for calcium phosphate nanoparticle transfection Biomaterials 2008, 29 (23) 3384
17. Josephson, L.; Tung, C.; Moore, A.; Weissleder, R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates Bioconjugate Chem. 1999, 10 (2) 186-191 (Pubitemid 29147720)
18. Kale, A.; Torchilin, V. Enhanced transfection of tumor cells in vivo using "Smart" pH-sensitive TAT-modified pegylated liposomes J. Drug Targeting 2007, 15 (7) 538-545 (Pubitemid 47209054)
19. MacKay, J.; Li, W.; Huang, Z.; Dy, E.; Huynh, G.; Tihan, T.; Collins, R.; Deen, D.; Szoka, F., Jr. HIV TAT peptide modifies the distribution of DNA nanolipoparticles following convection-enhanced delivery Mol. Ther. 2008, 16 (5) 893-900 (Pubitemid 351587099)
20. Moschos, S.; Williams, A.; Lindsay, M. Cell-penetrating-peptide-mediated siRNA lung delivery Biochem. Soc. Trans. 2007, 35, 807-810 (Pubitemid 47310373)
21. Pappalardo, J.; Quattrocchi, V.; Langellotti, C.; Di Giacomo, S.; Gnazzo, V.; Olivera, V.; Calamante, G.; Zamorano, P.; Levchenko, T.; Torchilin, V. Improved transfection of spleen-derived antigen-presenting cells in culture using TATp-liposomes J. Controlled Release 2009, 134 (1) 41-46
22. Suk, J.; Suh, J.; Choy, K.; Lai, S.; Fu, J.; Hanes, J. Gene delivery to differentiated neurotypic cells with RGD and HIV Tat peptide functionalized polymeric nanoparticles Biomaterials 2006, 27 (29) 5143-5150 (Pubitemid 43928121)
23. Manickam, S. Influence of TAT-peptide polymerization on properties and transfection activity of TAT/DNA polyplexes J. Controlled Release 2005, 102 (1) 293-306
24. Reschel, T. Physical properties and in vitro transfection efficiency of gene delivery vectors based on complexes of DNA with synthetic polycations J. Controlled Release 2002, 81 (1-2) 201-217 (Pubitemid 34454861)
25. Rudolph, C.; Plank, C.; Lausier, J.; Schillinger, U.; M ller, R.; Rosenecker, J. Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells J. Biol. Chem. 2003, 278 (13) 11411
26. Rudolph, C.; Schillinger, U.; Ortiz, A.; Tabatt, K.; Plank, C.; M ller, R.; Rosenecker, J. Application of novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo Pharm. Res. 2004, 21 (9) 1662-1669 (Pubitemid 41184398)
27. Hersmann, G. H. W.; Kriegsmann, J.; Simon, J.; Hüttich, C.; Bräuer, R. Expression of cell adhesion molecules and cytokines in murine antigen-induced arthritis Cell Commun. Adhes. 1998, 6 (1) 69-82
28. Swerlick, R. A.; Garcia-Gonzalez, E.; Kubota, Y.; Xu, Y.; Lawley, T. J. Studies of the Modulation of MHC Antigen and Cell Adhesion Molecule Expression on Human Dermal Microvascular Endotheliam Cells J. Invest. Dermatol. 1991, 97 (2) 190-196
29. Zecchinon, L.; Fett, T.; Vanden Bergh, P.; Desmecht, D. Bind another day: The LFA-1/ICAM-1 interaction as therapeutic target Clin. Appl. Immunol. Rev. 2006, 6 (3-4) 173-189 (Pubitemid 44896966)
30. Bevilacqua, M. P.; Nelson, R. M.; Mannori, G.; Cecconi, O. Endothelial-leukocyte adhesion molecules in human disease Annu. Rev. Med. 1994, 45 (1) 361-378 (Pubitemid 24158168)
31. Melis, M.; Spatafora, M.; Melodia, A.; Pace, E.; Gjomarkaj, M.; Merendino, A. M.; Bonsignore, G. ICAM-1 expression by lung cancer cell lines: effects of upregulation by cytokines on the interaction with LAK cells Eur. Respir. J. 1996, 9 (9) 1831
32. Chittasupho, C.; Xie, S. X.; Baoum, A.; Yakovleva, T.; Siahaan, T. J.; Berkland, C. J. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells Eur. J. Pharm. Sci. 2009, 37 (2) 141-150
33. Yacyshyn, B. R.; Chey, W. Y.; Goff, J.; Salzberg, B.; Baerg, R.; Buchman, A. L.; Tami, J.; Yu, R.; Gibiansky, E.; Shanahan, W. R. Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease Gut 2002, 51 (1) 30
34. Weller, G. E. R.; Villanueva, F. S.; Tom, E. M.; Wagner, W. R. Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx Biotechnol. Bioeng. 2005, 92 (6) 780-788 (Pubitemid 41772473)
35. Demos, S. M.; Alkan-Onyuksel, H.; Kane, B. J.; Ramani, K.; Nagaraj, A.; Greene, R.; Klegerman, M.; McPherson, D. D. In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement J. Am. Coll. Cardiol. 1999, 33 (3) 867-875
36. Muro, S.; Cui, X.; Gajewski, C.; Murciano, J. C.; Muzykantov, V. R.; Koval, M. Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress Am. J. Physiol. 2003, 285 (5) C1339
37. Murciano, J. C.; Muro, S.; Koniaris, L.; Christofidou-Solomidou, M.; Harshaw, D. W.; Albelda, S. M.; Granger, D. N.; Cines, D. B.; Muzykantov, V. R. ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface Blood 2003, 101 (10) 3977
38. Scherpereel, A.; Wiewrodt, R.; Christofidou-Solomidou, M.; Gervais, R.; Murciano, J. C.; Albelda, S. M.; Muzykantov, V. R. Cell-selective intracellular delivery of a foreign enzyme to endothelium in vivo using vascular immunotargeting FASEB J. 2001, 15 (2) 416
39. Yusuf-Makagiansar, H.; Yakovleva, T. V.; Tejo, B. A.; Jones, K.; Hu, Y.; Verkhivker, G. M.; Audus, K. L.; Siahaan, T. J. Sequence Recognition of -LFA-1-derived Peptides by ICAM-1 Cell Receptors: Inhibitors of T-cell Adhesion Chem. Biol. Drug Des. 2007, 70 (3) 237-246 (Pubitemid 47305397)
40. Anderson, M. E.; Siahaan, T. J. Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors Peptides 2003, 24 (3) 487
41. Zhao, H.; Kiptoo, P.; Williams, T.; Siahaan, T.; Topp, E. Immune response to controlled release of immunomodulating peptides in a murine experimental autoimmune encephalomyelitis (EAE) model. J. Controlled Release 2009.
42. Yonekawa, K.; Harlan, J. Targeting leukocyte integrins in human diseases J. Leukocyte Biol. 2005, 77 (2) 129
43. Yusuf-Makagiansar, H.; Siahaan, T. Binding and internalization of an LFA-1-derived cyclic peptide by ICAM receptors on activated lymphocyte: a potential ligand for drug targeting to ICAM-1-expressing cells Pharm. Res. 2001, 18 (3) 329-335 (Pubitemid 32595821)
44. Konno, S.; Grindle, K.; Lee, W.; Schroth, M.; Mosser, A.; Brockman-Schneider, R.; Busse, W.; Gern, J. Interferon-gamma enhances rhinovirus-induced RANTES secretion by airway epithelial cells Am. J. Respir. Cell Mol. Biol. 2002, 26 (5) 594
45. Fakhari, A; Baoum, A; Siahaan, T. J.; Le, K. B.; Berkland, C. Controlling Ligand Surface Density Optimizes Nanoparticle Binding to ICAM-1 J. Pharm. Sci. 2010, 100 (3) 1045-1056
46. Mansouri, S.; Lavigne, P.; Corsi, K.; Benderdour, M.; Beaumont, E.; Fernandes, J. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy Eur. J. Pharm. Biopharm. 2004, 57 (1) 1-8 (Pubitemid 38058799)
47. Veronese, F.; Pasut, G. PEGylation, successful approach to drug delivery Drug Discovery Today 2005, 10 (21) 1451-1458 (Pubitemid 41483874)
48. Won, Y.; Sharma, R.; Konieczny, S. Missing pieces in understanding the intracellular trafficking of polycation/DNA complexes J. Controlled Release 2009, 139, 88-93
49. Godbey, W.; Wu, K.; Mikos, A. Poly (ethylenimine)-mediated gene delivery affects endothelial cell function and viability Biomaterials 2001, 22 (5) 471-480 (Pubitemid 32007852)
50. Beyerle, A.; Merkel, O.; Stoeger, T.; Kissel, T. PEGylation affects cytotoxicity and cell-compatibility of poly (ethylene imine) for lung application: Structure-function relationships Toxicol. Appl. Pharmacol. 2010, 242 (2) 146-154
51. Zhang, X.; Pan, S.; Hu, H.; Wu, G.; Feng, M.; Zhang, W.; Luo, X. Poly (ethylene glycol)-block-polyethylenimine copolymers as carriers for gene delivery: Effects of PEG molecular weight and PEGylation degree J. Biomed. Mater. Res., Part A 2007, 84 (3) 795-804 (Pubitemid 351237797)
52. Palmer, L.; Chen, T.; Lam, A.; Fenske, D.; Wong, K.; MacLachlan, I.; Cullis, P. Transfection properties of stabilized plasmid-lipid particles containing cationic PEG lipids Biochim. Biophys. Acta, Biomembranes 2003, 1611 (1-2) 204-216 (Pubitemid 36351449)
53. Rungsardthong, U.; Deshpande, M.; Bailey, L.; Vamvakaki, M.; Armes, S. P.; Garnett, M. C.; Stolnik, S. Copolymers of amine methacrylate with poly (ethylene glycol) as vectors for gene therapy J. Controlled Release 2001, 73 (2-3) 359-380 (Pubitemid 32539263)
54. Köping-Höggård, M.; Vårum, K. M.; Issa, M.; Danielsen, S.; Christensen, B. E.; Stokke, B. T.; Artursson, P. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers Gene Ther. 2004, 11 (19) 1441-1452 (Pubitemid 39359435)
55. Fujita, T.; Furuhata, M.; Hattori, Y.; Kawakami, H.; Toma, K.; Maitani, Y. Calcium enhanced delivery of tetraarginine-PEG-lipid-coated DNA/protamine complexes Int. J. Pharm. 2009, 368 (1-2) 186-192
56. Sandhu, A.; Lam, A.; Fenske, D.; Palmer, L.; Johnston, M.; Cullis, P. Calcium enhances the transfection potency of stabilized plasmid-lipid particles Anal. Biochem. 2005, 341 (1) 156-164 (Pubitemid 40615732)
57. Shiraishi, T.; Pankratova, S.; Nielsen, P. Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic tat and oligoarginine peptides Chem. Biol. 2005, 12 (8) 923-929 (Pubitemid 41206806)
58. Liu, Z.; Li, M.; Cui, D.; Fei, J. Macro-branched cell-penetrating peptide design for gene delivery J. Controlled Release 2005, 102 (3) 699-710 (Pubitemid 40170212)
59. Ignatovich, I.; Dizhe, E.; Pavlotskaya, A.; Akifiev, B.; Burov, S.; Orlov, S.; Perevozchikov, A. Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways J. Biol. Chem. 2003, 278 (43) 42625
60. Moghimi, S.; Symonds, P.; Murray, J.; Hunter, A.; Debska, G.; Szewczyk, A. A two-stage poly (ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy Mol. Ther. 2005, 11 (6) 990-995 (Pubitemid 40724119)
61. Xiang, S. D.; Scholzen, A.; Minigo, G.; David, C.; Apostolopoulos, V.; Mottram, P. L.; Plebanski, M. Pathogen recognition and development of particulate vaccines: does size matter? Methods 2006, 40 (1) 1-9 (Pubitemid 44415493)
62. Beg, A.; Baltimore, D. An essential role for NF-kappa B in preventing TNF-alpha-induced cell death Science 1996, 274 (5288) 782
63. Li, L.; Thomas, R.; Suzuki, H.; De Brabander, J.; Wang, X.; Harran, P. A small molecule Smac mimic potentiates TRAIL-and TNF {alpha}-mediated cell death Science 2004, 305 (5689) 1471
64. Foerg, C.; Merkle, H. P. On the biomedical promise of cell penetrating peptides: limits versus prospects J. Pharm. Sci. 2007, 97 (1) 144-162